Boric Acid Marco Viti Cutaneous Solution 3% Antiseptic 500ml

Boric Acid Marco Viti 3% 500ml

PHARMACOTHERAPEUTIC CATEGORY: Antiseptics and disinfectants.

ACTIVE INGREDIENTS: Boric acid 3 g. EXCIPIENTS: Sodium benzoate, methyl parahydroxybenzoate, ethyl parahydroxybenzoate, propyl parahydroxybenzoate, sodium hydroxide, propylene glycol, purified water.

INDICATIONS: Antiseptic for the disinfection of minor burns and irritated or chapped skin areas; the solution is also used in the form of local buffers with a decongestant action; boric acid is indicated as an antibacterial for the treatment of acne.

CONTRAINDICATIONS / SECONDAR EFFECTS: Hypersensitivity to the active substance or to any of the excipients; extensive skin lesions; children under 3 years of age.

DOSAGE: External use: apply as needed on the affected area. Adults: Boric acid can be applied directly once or twice a day or to inflamed areas in case of chapped, irritated or dry skin, abrasions, mild burns, sunburn, wind burns or insect bites. Children over 3 years of age: Boric acid can be applied directly once or twice a day to inflamed areas associated with chapped, irritated or dry skin, diaper rash, mild sunburn, sunburn, wind or windburn. insect bites.

STORAGE: Keep the container tightly closed to protect the medicine from light.

WARNINGS: Excessive and prolonged application on large areas or on damaged skin can cause accumulation toxicity. The medicinal product must not be used for ophthalmic use. The medicine contains parahydroxybenzoates; sodium benzoate and propylene glycol.

INTERACTIONS: There are no known interactions between boric acid for external use and other medicinal products.

UNDESIRABLE EFFECTS: The absorption of boric acid through the intact skin is less than 0.5%; however it may increase if accidentally administered systemically or applied to wounds or lesions. The undesirable effects of boric acid occurring in the case of accumulation toxicity, after prolonged exposure and following systemic absorption, are reported below. These effects are organized according to the MedDRA organic systemic classification. Sufficient data are not available to establish the frequency of the individual effects listed. Diseases of the skin and subcutaneous tissue: dermatitis, rashes and, alopecia. Gastrointestinal disorders: gastrointestinal disorders: nausea, vomiting, diarrhea. Metabolism and nutrition disorders: anorexia. Endocrine disorders: menstrual disorders. Blood and lymphatic system disorders: anemia. Musculoskeletal and connective tissue disorders: weakness. Psychiatric disorders: confusion. Nervous system disorders: convulsions.